Omeprazole Apteo Med (Omeprazole)

Omeprazole is a proton pump inhibitor used to treat conditions caused by excess gastric acid.

• Gastroesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation.
• Peptic ulcer disease: facilitates ulcer healing and prevents recurrence.
• Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic therapy by suppressing acid.
• Zollinger‑Ellison syndrome: controls hypersecretion of gastric acid associated with gastrin‑producing tumors.

• Omeprazole irreversibly binds to the H+/K+ ATPase enzyme (gastric proton pump) located on the secretory surface of parietal cells, blocking the final step of acid production. This inhibition leads to a prolonged reduction in gastric acidity, allowing mucosal healing and symptom relief in acid‑related disorders.

Common side effects are generally mild and transient.

Common Side Effects

• Headache: mild to moderate pain often resolving without intervention.
• Diarrhea: loose stools that may improve with continued therapy.
• Abdominal pain: discomfort or cramping in the stomach area.
• Nausea: feeling of sickness, sometimes accompanied by vomiting.
• Flatulence: increased gas production.
• Constipation: difficulty passing stools.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
• Severe allergic reactions: rash, swelling, or anaphylaxis requiring immediate medical attention.
• Stevens‑Johnson syndrome: rare skin blistering and mucosal involvement.
• Liver enzyme elevations: potential hepatotoxicity indicated by abnormal lab tests.
• Hypomagnesemia: low magnesium levels with long‑term use, causing muscle cramps or arrhythmias.
• Interstitial nephritis: inflammation of kidney tissue that may impair renal function.

Before initiating therapy, consider the following safety measures.

• Assess renal function: adjust use in patients with severe impairment.
• Monitor for infection: prolonged acid suppression can increase risk of C. difficile.
• Check magnesium levels: long‑term therapy may cause deficiency.
• Avoid abrupt discontinuation: may lead to rebound acid hypersecretion.
• Pregnancy and lactation: use only if potential benefit outweighs risk.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Omeprazole may alter the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
• Atazanavir: decreased absorption, compromising antiviral efficacy.
• High‑dose methotrexate: increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR, requiring more frequent monitoring.
• Diazepam: elevated serum concentrations, may enhance sedation.
• Digoxin: higher plasma levels, increasing risk of toxicity.